Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Metabolic Syndrome in Patients of a Psychosocial Care Center in Brazil: A Cross-Sectional Study

Version 1 : Received: 26 November 2021 / Approved: 30 November 2021 / Online: 30 November 2021 (10:38:08 CET)

How to cite: Silva, D.A.R.D.A.R.D.; Almeida, L.S.D.; Correa, L.L.; Pimentel, R.F.W.; Gomes, A.M.T.; Travassos, A.G.; Viana, A.M.; Cerqueira, M.M.M.B.D.F.; Souza, M.C.D.; de Sousa, A.R.; Barbosa, P.J.B.; Coelho, J.M.F.; Magalhães, L.B.N.C.; D’Oliveira Júnior, A.; Cavalcante Neto, J.L.; Santos, C.S.; França, L.C.M.; Brandão, J.D.L.; Santos, L.F.D.M.D.; Gomes, H.F.; Peres, E.M.; Rossi, T.R.A.; Damasceno, K.S.M.; Merces, M.C.D. Metabolic Syndrome in Patients of a Psychosocial Care Center in Brazil: A Cross-Sectional Study. Preprints 2021, 2021110554. https://doi.org/10.20944/preprints202111.0554.v1 Silva, D.A.R.D.A.R.D.; Almeida, L.S.D.; Correa, L.L.; Pimentel, R.F.W.; Gomes, A.M.T.; Travassos, A.G.; Viana, A.M.; Cerqueira, M.M.M.B.D.F.; Souza, M.C.D.; de Sousa, A.R.; Barbosa, P.J.B.; Coelho, J.M.F.; Magalhães, L.B.N.C.; D’Oliveira Júnior, A.; Cavalcante Neto, J.L.; Santos, C.S.; França, L.C.M.; Brandão, J.D.L.; Santos, L.F.D.M.D.; Gomes, H.F.; Peres, E.M.; Rossi, T.R.A.; Damasceno, K.S.M.; Merces, M.C.D. Metabolic Syndrome in Patients of a Psychosocial Care Center in Brazil: A Cross-Sectional Study. Preprints 2021, 2021110554. https://doi.org/10.20944/preprints202111.0554.v1

Abstract

Background: Metabolic syndrome (MS) is associated with a greater risk of morbimortality. Ob-jective: To estimate the prevalence of Metabolic Syndrome (MS) and associated factors in patients of a Psychosocial Care Center (CAPS) in the city of Salvador, state of Bahia, Brazil. Method: Cross-sectional study set at CAPS in the city of Salvador-Bahia, between August 2019 and February 2020. MS was evaluated according to the National Cholesterol Education Program's Adult Treatment Panel III. In addition to descriptive statistics, gross and adjusted prevalence ratios were described. Results: MS was found in 100 (35.2%) individuals, 116 (40.9%) were obese and 165 (58.1%) had increased waist circumference. Polypharmacy was identified in 63 (22.3%) patients and 243 (85.9%) used antipsychotics. In the gross evaluation, the female (PR = 1.88; 95% CI: 1.35-2.63) and the use of antidepressants (PR = 1.41; 95%CI: 1.05-1.88) were associated with MS. After logistic re-gression, depression (PR = 1.86; 95%CI: 1.38-2.51), acanthosis (PR = 1.50; 95%CI: 1.18 - 1.90), use of antipsychotics (PR = 1.88; 95%CI: 1.13 - 2.75) and the hypertriglyceremic waist (PR = 3.33; 95%CI: 2.48- 4.46) were associated with MS. Conclusion: The prevalence of MS alerts to multimorbidity among individuals with mental disorders and the need for clinical screening.

Keywords

Metabolic syndrome; Mental disorders; Obesity; Multimorbidity

Subject

Medicine and Pharmacology, Psychiatry and Mental Health

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.